Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RAY Y HACHEM and ANNE-MARIE P CHAFTARI.
RAY Y HACHEM
Connection Strength
4.851
ANNE-MARIE P CHAFTARI
  1. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother. 2024 Oct 01; 79(10):2543-2553.
    View in: PubMed
    Score: 0.247
  2. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
    View in: PubMed
    Score: 0.220
  3. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac079.
    View in: PubMed
    Score: 0.206
  4. Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model. Wound Repair Regen. 2021 09; 29(5):830-842.
    View in: PubMed
    Score: 0.195
  5. Advances in the prevention and management of central-line-associated bloodstream infections: The role of chelator-based catheter locks. Infect Control Hosp Epidemiol. 2019 09; 40(9):1036-1045.
    View in: PubMed
    Score: 0.172
  6. International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients. Mediterr J Hematol Infect Dis. 2019; 11(1):e2019003.
    View in: PubMed
    Score: 0.166
  7. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients. Infect Control Hosp Epidemiol. 2018 06; 39(6):727-729.
    View in: PubMed
    Score: 0.159
  8. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol. 2018 02; 39(2):222-225.
    View in: PubMed
    Score: 0.155
  9. Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients". Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.150
  10. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents. 2017 Sep; 50(3):384-388.
    View in: PubMed
    Score: 0.150
  11. A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.150
  12. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Antimicrob Agents Chemother. 2017 04; 61(4).
    View in: PubMed
    Score: 0.147
  13. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother. 2016 06; 60(6):3426-32.
    View in: PubMed
    Score: 0.139
  14. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infect Dis. 2014 Sep 24; 14:518.
    View in: PubMed
    Score: 0.124
  15. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother. 2014 Nov; 69(11):3148-55.
    View in: PubMed
    Score: 0.122
  16. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol. 2013 Jul; 24(7):1873-1879.
    View in: PubMed
    Score: 0.111
  17. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation. 2012 Aug 15; 94(3):302-8.
    View in: PubMed
    Score: 0.107
  18. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother. 2012 Feb; 56(2):935-41.
    View in: PubMed
    Score: 0.102
  19. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes. Biomaterials. 2011 Apr; 32(11):2689-94.
    View in: PubMed
    Score: 0.096
  20. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer. 2011 Jun 01; 117(11):2551-8.
    View in: PubMed
    Score: 0.095
  21. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
    View in: PubMed
    Score: 0.091
  22. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel). 2024 Oct 11; 16(20).
    View in: PubMed
    Score: 0.062
  23. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC Antimicrob Resist. 2024 Apr; 6(2):dlae060.
    View in: PubMed
    Score: 0.060
  24. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers (Basel). 2024 Mar 05; 16(5).
    View in: PubMed
    Score: 0.059
  25. In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist. 2023 Dec; 5(6):dlad132.
    View in: PubMed
    Score: 0.058
  26. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife. 2023 02 07; 12.
    View in: PubMed
    Score: 0.055
  27. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. Elife. 2022 12 21; 11.
    View in: PubMed
    Score: 0.055
  28. Prevention of device-related infections in patients with cancer: Current practice and future horizons. CA Cancer J Clin. 2023 03; 73(2):147-163.
    View in: PubMed
    Score: 0.054
  29. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. J Fungi (Basel). 2022 Jan 13; 8(1).
    View in: PubMed
    Score: 0.051
  30. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.
    View in: PubMed
    Score: 0.051
  31. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med. 2021 12; 10(23):8475-8482.
    View in: PubMed
    Score: 0.051
  32. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel). 2021 Aug 13; 13(16).
    View in: PubMed
    Score: 0.050
  33. Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infect Dis. 2021 Jul 05; 21(1):643.
    View in: PubMed
    Score: 0.049
  34. Is a single dose of mRNA vaccine sufficient for COVID-19 survivors? J Med Virol. 2021 Jul; 93(7):4083-4084.
    View in: PubMed
    Score: 0.048
  35. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours. J Hosp Infect. 2020 Mar; 104(3):358-364.
    View in: PubMed
    Score: 0.044
  36. Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia. Open Forum Infect Dis. 2019 Oct; 6(10):ofz357.
    View in: PubMed
    Score: 0.044
  37. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 07; 63(7).
    View in: PubMed
    Score: 0.043
  38. Corrigendum to "Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?" [Diagn Microbiol Infect Dis 2019;76(2):158-161]. Diagn Microbiol Infect Dis. 2019 05; 94(1):105.
    View in: PubMed
    Score: 0.042
  39. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC Infect Dis. 2018 Dec 13; 18(1):656.
    View in: PubMed
    Score: 0.041
  40. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy. Open Forum Infect Dis. 2018 Oct; 5(10):ofy249.
    View in: PubMed
    Score: 0.041
  41. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes. Ann Med. 2018 12; 50(8):713-720.
    View in: PubMed
    Score: 0.041
  42. Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer. Clin Infect Dis. 2018 08 31; 67(6):971-977.
    View in: PubMed
    Score: 0.041
  43. Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden. Expert Rev Med Devices. 2018 Aug; 15(8):591-596.
    View in: PubMed
    Score: 0.040
  44. Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 Apr 19; 8(1):6258.
    View in: PubMed
    Score: 0.040
  45. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 01 18; 8(1):1099.
    View in: PubMed
    Score: 0.039
  46. Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm. Front Microbiol. 2017; 8:1999.
    View in: PubMed
    Score: 0.038
  47. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control. 2017 Mar 01; 45(3):e34-e39.
    View in: PubMed
    Score: 0.037
  48. Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia. J Fungi (Basel). 2017 Feb 10; 3(1).
    View in: PubMed
    Score: 0.036
  49. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. Antimicrob Agents Chemother. 2016 09; 60(9):5175-81.
    View in: PubMed
    Score: 0.035
  50. Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism. Medicine (Baltimore). 2016 Apr; 95(14):e2691.
    View in: PubMed
    Score: 0.034
  51. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. Am J Infect Control. 2016 09 01; 44(9):1037-40.
    View in: PubMed
    Score: 0.034
  52. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit Care Med. 2014 Dec; 42(12):2500-7.
    View in: PubMed
    Score: 0.031
  53. Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters. Antimicrob Agents Chemother. 2014 Sep; 58(9):5291-6.
    View in: PubMed
    Score: 0.030
  54. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med. 2014 May; 46(3):163-8.
    View in: PubMed
    Score: 0.030
  55. Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother. 2014; 58(2):1179-82.
    View in: PubMed
    Score: 0.029
  56. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia? Diagn Microbiol Infect Dis. 2013 06; 76(2):158-61.
    View in: PubMed
    Score: 0.028
  57. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis. 2013 Apr; 56(7):943-50.
    View in: PubMed
    Score: 0.027
  58. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis. 2013 Mar; 56(6):843-6.
    View in: PubMed
    Score: 0.027
  59. Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol. 2013 Jan; 189(1):130-5.
    View in: PubMed
    Score: 0.027
  60. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer. 2012 Dec 01; 118(23):5823-9.
    View in: PubMed
    Score: 0.026
  61. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One. 2012; 7(3):e32945.
    View in: PubMed
    Score: 0.026
  62. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8.
    View in: PubMed
    Score: 0.025
  63. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011 Feb; 39(2):245-51.
    View in: PubMed
    Score: 0.024
  64. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009 Oct 15; 49(8):1187-94.
    View in: PubMed
    Score: 0.022
  65. Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore). 2009 Sep; 88(5):279-283.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.